K. Gadde
The Lancet · 2011
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom K. Gadde trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from K. Gadde's perspective
Ordered by how strongly the researchers K. Gadde trusts endorse each paper. Same corpus, a different order for every researcher.
- Bariatric surgery: a systematic review and meta-analysis. (Journal of the American Medical Association (JAMA))
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. (The Lancet)
- Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. (Journal of the American Dietetic Association)
- Statistical considerations in the intent-to-treat principle. (Controlled Clinical Trials)
- Analysis of Incomplete Multivariate Data (Monographs on Statistics and Applied Probability, No. 72)
- Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. (New England Journal of Medicine)
- Prevalence and trends in obesity among US adults, 1999-2008. (Journal of the American Medical Association (JAMA))
- Statistical Analysis With Missing Data
- Longitudinal data analysis using generalized linear models
- Intention to treat in clinical trials
Their papers
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. (2011) — 878 citations
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) (2011) — 629 citations